Description

Octapharma Human Albumin 25% is produced from large pools of screened human plasma and processed via cold ethanol fractionation, ultrafiltration, and pasteurization to ensure high purity and viral safety. This concentration provides potent oncotic pressure with minimal fluid load. In laboratory research, it is used to simulate hypovolemia correction, protein binding dynamics assays, colloid osmotic models, and carry?over experiments in pharmacokinetics. Packaged as 12.5?g in 50?ml single-use vials. Strictly for laboratory research use only.

Product Specifications

Mechanism of Action & Research Applications

Human albumin contributes significantly to colloid osmotic pressure, stabilizes circulating volume, and binds hormones, drugs, fatty acids, and bilirubin. In research, Octapharma Human Albumin 25% is frequently used to model rapid plasma volume expansion, assess drug-binding kinetics, mimic critical care fluid therapy, and explore transport protein dynamics in cell culture, animal models, and pharmacological studies.

Side Effects (For Reference Only in Research Models)

Model systems or analogous clinical observations may include transient hypertension or hypotension, fluid overload, allergic reactions, headaches, and rare thrombotic events. These findings guide safety monitoring and dose planning in experimental designs.

Disclaimer

Octapharma Human Albumin 25% is strictly intended for laboratory research use only. Not for human or veterinary therapeutic or diagnostic use.